Real-time enrollment status for this major depressive disorder clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 8:43 AM UTC
| NCT Number | NCT06911112 |
| Recruiting Status | Recruiting |
| Condition | Major Depressive Disorder |
| Phase | Clinical Trial |
| Target Enrollment | 200 participants |
| Active Locations | 10 sites in the US |
| Sponsor | Neurocrine Biosciences |
| Last Updated on CT.gov | December 1, 2025 (Dec 1, 2025) |
As of July 13, 2026: Clinical trial NCT06911112 is currently recruiting participants. This clinical trial study for major depressive disorder is actively seeking new participants at 10 locations across the United States. The study is sponsored by Neurocrine Biosciences. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06911112 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 10 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06911112 was last updated Dec 1, 2025 (December 1, 2025). HelloStudys verifies this status automatically.